making muscle wasting history

Utrophin update April 2009

• Last Edited: 1 May 2009
• Permanent link

This is the latest update from Biomarin with regard to Utrophin.In the first quarter of 2009, BioMarin recorded impairment loss on investments of $5.9 million, comprised of $1.4 million related to...

Tags: utrophin, biomarin, summit.

Summit pass pre-clinical development to Biomarin

• Last Edited: 29 May 2009
• Permanent link

New investor email out today, see below:Restructuring of Duchenne muscular dystrophy agreement with BioMarinSummit and BioMarin have recently restructured their agreement for the Duchenne muscular...

Tags: summit, biomarin, utrophin, utrophin upregulation, SMT C1100.

BioMarin Announces Results for Phase 1 Clinical Study of BMN 195

• Last Edited: 2 Aug 2010
• Permanent link

Novato, Calif, August 2, 2010 – BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that it has completed the Phase 1 clinical study of BMN 195, a small molecule utrophin up-regulator...

Tags: utrophin upregulation, Biomarin, BMN 195.